Alex Zhavoronkov - CEO Insilico Medicine

In this episode of Life Science Success my Guest is Alex Zhavoronkov. Alex is the CEO Insilico Medicine an AI-powered drug discovery company.

• Insilico Medicine has progressed three internally-derived assets into human clinical trials.
• Insilico Medicine has discovered over 30 other programs in different stages.
• Insilico Medicine incorporates three engines in their platform: biology, chemistry, and clinical.
• They generate normal molecules with desired properties using 42 generative engines.
• They have a system that predicts clinical trials outcomes.
• Insilico Medicine’s main strategy is partnering with pharma companies at the preclinical candidate stage.
• They value patient first, relentless innovation, and transparency and integrity.
• Alex's biggest concern is human tendency to prioritize unimportant things over important ones.
• Alex is excited about large language models, multimodal generative AI, robotics, and quantum computing.